论文部分内容阅读
目的:了解我国抗高血压药物的利用情况及用药趋势,为改善人群高血压治疗水平提供依据。方法:对上海市近3年15种主要抗高血压药物消耗量的动态变化进行了调查。结果:近3年来,上海市抗高血压药物的增长以钙拮抗剂增长最快,尤其是新型钙拮抗剂—氮氯地平,硝苯地平也稳定增长;新型ACE抑制剂—苯那普利增长明显,卡托普利保持稳定。利尿剂—吲哒胺也增长明显;β受体阻滞剂用量较大且保持稳定。传统复方剂型的降压药—复方降压片,在消耗量上仍占主导地位,但其用量逐年明显下降。结论:居主导地位的是钙拮抗剂及其复方制剂,以新型钙拮抗剂增长最快,药物利用的次序是硝苯地平、复方制剂、β受体阻滞剂、新型钙拮抗剂、ACE抑制剂、利尿剂和α受体阻滞剂;从用药金额来看,则为ACE抑制剂、新型钙拮抗剂、β受体阻滞剂、硝苯地平、α受体阻滞剂、复方制剂和利尿剂。
Objective: To understand the utilization of antihypertensive drugs and medication trends in our country to provide evidence for improving the treatment of hypertension in the population. Methods: The dynamic changes of 15 main antihypertensive drugs in Shanghai during the recent 3 years were investigated. Results: In the recent three years, the growth of antihypertensive drugs in Shanghai has the fastest growth of calcium antagonists, especially the new type of calcium antagonist, nitrendipine and nifedipine. The growth of new ACE inhibitor, benazapril, Clearly, captopril remained stable. Diuretics - indapamide also increased significantly; β-blockers larger and stable. The traditional compound prescription type antihypertensive drugs - compound antihypertensive tablets, the consumption is still dominant, but the amount dropped year by year. CONCLUSION: The dominance of calcium antagonists and their combination preparations is the new type of calcium antagonist which has the fastest growth rate. The order of drug use is nifedipine, compound preparation, beta-blocker, novel calcium antagonist, ACE inhibition Agents, diuretics and alpha blockers; from the point of view of the amount of medication, ACE inhibitors, new calcium antagonists, beta blockers, nifedipine, alpha blockers, combination and Diuretic.